By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Quanta BioSciences today announced a partnership with Integrated DNA Technologies for the manufacture of assays for quantifying microRNAs.

Under the terms of the deal, IDT will produce the assays and market them through an online catalog directly to customers of Quanta.

Financial and other terms of the deal were not disclosed.

Based in Gaithersburg, Md., Quanta develops reagents for PCR, qPCR, and cDNA applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.